Fayez Sarofim & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332M | Sell |
|
|||||
|
2025
Q1 | $366M | Buy |
|
|||||
|
2024
Q4 | $305M | Buy |
|
|||||
|
2024
Q3 | $326M | Buy |
|
|||||
|
2024
Q2 | $300M | Buy |
|
|||||
|
2024
Q1 | $238M | Buy |
|
|||||
|
2023
Q4 | $226M | Buy |
|
|||||
|
2023
Q3 | $145M | Buy |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $68.4M | Buy |
|
|||||
|
2022
Q4 | $53M | Buy |
|
|||||
|
2022
Q3 | $11.2M | Buy |
|
|||||
|
2022
Q2 | $11M | Buy |
|
|||||
|
2022
Q1 | $9.41M | Buy |
|
|||||
|
2021
Q4 | $8.76M | Buy |
|
|||||
|
2021
Q3 | $6.8M | Sell |
|
|||||
|
2021
Q2 | $6.79M | Buy |
|
|||||
|
2021
Q1 | $5.17M | Sell |
|
|||||
|
2020
Q4 | $5.38M | Sell |
|
|||||
|
2020
Q3 | $4.83M | Buy |
|
|||||
|
2020
Q2 | $4.25M | Sell |
|
|||||
|
2020
Q1 | $5.6M | Buy |
|
|||||
|
2019
Q4 | $5.25M | Buy |
|
|||||
|
2019
Q3 | $1.85M | Buy |
|
|||||
|
2019
Q2 | $1.83M | Sell |
|
|||||
|
2019
Q1 | $9.87M | Buy |
|
|||||
|
2018
Q4 | $1.78M | Buy |
|
|||||
|
2018
Q3 | $1.59M | Buy |
|
|||||
|
2018
Q2 | $1.22M | Sell |
|
|||||
|
2018
Q1 | $1.32M | Buy |
|
|||||
|
2017
Q4 | $1.38M | Sell |
|
|||||
|
2017
Q3 | $1.4M | Hold |
|
|||||
|
2017
Q2 | $1.35M | Sell |
|
|||||
|
2017
Q1 | $1.67M | Hold |
|
|||||
|
2016
Q4 | $1.46M | Sell |
|
|||||
|
2016
Q3 | $2.18M | Sell |
|
|||||
|
2016
Q2 | $2.34M | Buy |
|
|||||
|
2016
Q1 | $2.05M | Sell |
|
|||||
|
2015
Q4 | $2.82M | Buy |
|
|||||
|
2015
Q3 | $2.56M | Hold |
|
|||||
|
2015
Q2 | $2.56M | Sell |
|
|||||
|
2015
Q1 | $2.28M | Sell |
|
|||||
|
2014
Q4 | $2.17M | Sell |
|
|||||
|
2014
Q3 | $2.06M | Buy |
|
|||||
|
2014
Q2 | $1.96M | Buy |
|
|||||
|
2014
Q1 | $1.84M | Sell |
|
|||||
|
2013
Q4 | $1.61M | Buy |
|
|||||
|
2013
Q2 | $1.6M | Buy |
|